Go to University of Chicago Medicine Home

Improving the Doctor-Patient Relationship
through Patient Care, Teaching and Research.

Master Clinicians

Each year the Bucksbaum Institute will provide substantial funding, to recruit one experienced physician-teacher or to appoint a senior physician hired in the last 12-14 months, each year to the University who will serve for three years as a Bucksbaum Master Clinician. These physicians will be role models for student scholars and faculty scholars in the delivery of excellent clinical care and skilled doctor-patient communication.

Master Clinician
Selwyn O. Rogers, Jr., MD, MPH

Selwyn O. Rogers, Jr., MD, MPH (2018)
Department of Surgery

Selwyn Rogers, Jr., MD, MPH, FACS, has been named the new section chief of Trauma and Acute Care Surgery at the University of Chicago Medicine. Dr. Rogers is an acclaimed critical care surgeon and public health expert who has served in leadership capacities at health centers across the country, including most recently as vice president and chief medical officer for the University of Texas Medical Branch at Galveston. Dr. Rogers has also served as the chairman of surgery at Temple University School of Medicine and as the division chief of Trauma, Burn and Surgical Critical Care at Harvard Medical School. While at Brigham and Women's Hospital (BWH), he helped launch the Center for Surgery and Public Health to understand the nature, quality and utilization of surgical care nationally and internationally.

Dr. Rogers is a prolific researcher, and his work seeks to improve quality and access to care for all patients. Among other topics, his published research has looked at the impact of race and ethnicity on surgical outcomes. He is committed to improving the understanding of disparities in surgical care to close the quality chasm for underserved populations and provide the most patient-centered care possible.

Beyond trauma and surgical critical care, Dr. Rogers has been an advocate for treating intentional violence as a public health problem. In partnership with the Center for Community Health and Health Equity at BWH, he developed a violence intervention and prevention program that worked to address the social factors that put patients at increased risk for trauma and mortality such as poverty, hopelessness, and lack of opportunity. The program partners with organizations in Boston to educate youth about community violence and connects victims with the resources they need to heal.

Dr. Rogers earned his medical degree from Harvard Medical School and completed both his surgery residency and an NIH research fellowship in surgical oncology at BWH in Boston. He completed a surgical critical care fellowship at Massachusetts General Hospital and BWH. Additionally, Dr. Rogers has a master’s degree in public health from Vanderbilt University.

Kathryn Colby, MD, PhD

Kathryn Colby, MD, PhD (2017)
Department of Ophthalmology and Visual Science

Kathryn Colby, MD, PhD is the Louis Block Professor of Ophthalmology and Visual Science and the Chair of the Department of Ophthalmology & Visual Science.

Dr. Colby is an internationally renowned ophthalmologist with expertise in managing complex medical and surgical diseases of the cornea and ocular surface. Dr. Colby has a particular interest in Fuchs’ dystrophy, the most common cause for corneal transplantation in the United States, and is currently pioneering novel treatments for this condition. In addition, she has specific expertise in the management of ocular surface tumors, including conjunctival melanoma and squamous cell carcinoma.

Dr. Colby is an active researcher whose contributions have enhanced outcomes for patients who require keratoprosthesis (artificial cornea) surgery. She has an ongoing interest in corneal infections and has published extensively in this area. Dr. Colby was instrumental in determining the optimal surgical techniques for placement of the implantable miniature telescope, a vision-rehabilitative device for patients with macular degeneration.

Dr. Colby is a passionate educator who trained hundreds of medical students, ophthalmology residents and cornea fellows during the two decades she spent at Harvard Medical School prior to coming to the University of Chicago to lead the Department of Ophthalmology and Visual Science. She lectures around the world on numerous corneal and clinical research topics. She has leadership roles in various national and international societies, including the American Academy of Ophthalmology and the Cornea Society.

Arlene Chapman, MD

Arlene Chapman, MD (2016)
Department of Medicine

A renowned nephrologist, Arlene Chapman, MD, is dedicated to improving the lives of patients with renal disease. Dr. Chapman’s career has focused on hereditary renal diseases. Dr. Chapman also sees patients with chronic kidney disease of all causes, and those who are pregnant with underlying renal disease.

Dr. Chapman studies personalized or precision medicine and the role that genetic background plays in predicting antihypertensive responses to blood pressure medications used to treat hypertension. Dr. Chapman's early investigations centered on the renal and systemic changes to blood circulation that occur during preeclampsia. She has received continuous funding for her work from the National Institutes of Health (NIH) over the past 18 years.

Dr. Chapman’s academic contributions include membership on several NIH committees as well as the Scientific Advisory Council for the Polycystic Kidney Disease Research Foundation and the Council for the American Kidney Societies. Dr. Chapman is the current director of the Clinical Resource Center for the Institute of Translational Medicine in the Biological Sciences Division at the University of Chicago. She has published nearly 170 peer-reviewed publications and book chapters, and previously served on the editorial boards for American Journal of Kidney Diseases, Kidney International and the Journal of the American Society of Nephrology.

In addition, Dr. Chapman is a dedicated mentor and educator for medical students, interns and residents. She is actively involved in teaching fellows about various topics in nephrology and guides them in their research.

Neil Hyman, MD

Neil Hyman, MD (2015)
Department of Surgery

Dr. Hyman received his BA from the University of Pennsylvania in 1980 and his M.D. from the University of Vermont College of Medicine in 1984. He completed his surgical internship and residency at the Mount Sinai Medical Center in New York, New York, and his colon and rectal fellowship at the Cleveland Clinic Foundation in Cleveland, Ohio.

Dr. Hyman is currently Professor of Surgery, Chief of the Section of Colon and Rectal Surgery and Codirector of the Center for Digestive Diseases at the University of Chicago Medicine. He has authored more than 175 peer-reviewed original articles or textbook chapters.

Dr. Hyman serves on many regional and national committees, and is a member of numerous national organizations and societies. He has been President of the Vermont Chapter of the American College of Surgeons, Associate Editor of Diseases of the Colon and Rectum, Principle Investigator of the New England and Vermont Colorectal Cancer Quality Project, and Chairman of the Standards Committee of the American Society of Colon and Rectal Surgeons. He is Treasurer of the American Society of Colon and Rectal Surgeons and its Research Foundation, serves on the Board of Directors of the American Board of Colon and Rectal Surgery, is a member of the Editorial Board of the Journal of Gastrointestinal Surgery and Chairs the ACS Advisory Council for Colon and Rectal Surgery.

He is the recipient of many teaching awards including Clinical Teacher of the Year, University of Vermont, College of Medicine 1993/94, 1994/95 and 1997/98. He has received the Jerome S. Abrams Teaching Award in 1992/93, 1993/94 and 1997/98, the Howe Outstanding Surgery Faculty Award 2000/2001, 2004/2005, 2010/2011 and the Humanism in Medicine Award, University of Vermont, College of Medicine 2001/02. He was designated as Teacher of the Year by the Chief Surgical Residents in 1991, 2007, 2009 and 2014 at UVM, and at the University of Chicago where he received the Robert Baker Award for Excellence in Teaching in 2015.

In 2005, he delivered the Commencement Address at the UVM College of Medicine graduation, was voted as Physician of the Year by the Vermont State Medical Society in 2011, and received the Distinguished Academic Achievement Award from the Alumni Association of the University of Vermont College of Medicine in 2014.

Nir Uriel, MD

Nir Uriel, MD (2015)
Department of Medicine

Dr. Nir Uriel is an Associate Professor of Medicine and is the Director of the Heart Failure, Transplant and Mechanical Circulatory Support. Dr. Uriel is a leader in the field of heart failure, mechanical circulatory support and heart transplantation. He specializes in caring for patients who require mechanical circulatory support, including ventricular assist devices (VADs). Dr. Uriel’s research focuses on advanced heart failure physiology, heart transplant and mechanical circulatory support. He has a strong interest in high-risk transplant populations, including HIV-positive patients and patients who have received mediastinal radiation due to tumors or prior transplants. Through his research, Dr. Uriel has improved treatment protocols and patient care for these high-risk groups. Dr. Uriel has published more than 80 original, peer-reviewed articles.

Douglas Dirschl, MD

Douglas Dirschl, MD (2014)
Department of Orthopaedic Surgery and Rehabilitative Medicine

Douglas R. Dirschl, MD, is a highly accomplished surgeon and an expert in orthopaedics. He specializes in caring for patients with musculoskeletal trauma and fractures, as well as other injuries and diseases of the bones, joints and muscles.

Dr. Dirschl’s research focuses on the assessment of factors that influence reliability in classifying fractures. He has studied the quality of radiographs, as well as the use of decision-making strategies to enhance reliability. Dr. Dirschl also studies the biological basis of surgery, including the relationship between hemorrhage in pelvic fractures and pelvic bleeding. His research has been funded by the National Institutes of Health (NIH).

A leader in medical education and health policy, Dr. Dirschl teaches medical students, residents and physicians about orthopaedic trauma, musculoskeletal pathophysiology and fractures. He has authored three books, more than 30 book chapters, and more than 75 peer-reviewed scholarly articles. In addition, Dr. Dirschl sits on editorial and review boards for several notable scientific journals, including the Journal of Orthopaedic Research, Journal of Orthopaedic Trauma, and Journal of Bone and Joint Surgery.

Dr. Dirschl previously served as president of the American Orthopaedic Association.

Jessica Kandel, MD

Jessica Kandel, MD (2014)
Departments of Surgery and Pediatrics

Jessica J. Kandel, MD, is an expert in pediatric surgery. She specializes in the treatment of pediatric cancers, including Wilms tumor, neuroblastoma and hepatoblastoma, as well as vascular anomalies (hemangiomas, venous malformations, lymphatic malformations).

Dr. Kandel’s research focuses on the development and differentiation of blood vessels (angiogenesis) in solid tumors and vascular anomalies. She was a leader in early studies that suppressed tumor growth by blocking vascular endothelial growth factor, a protein that stimulates angiogenesis. Dr. Kandel’s work contributed to the development of bevacizumab, a drug used to manage metastatic colorectal, lung, and kidney cancers.

As the primary investigator on several long-term studies, Dr. Kandel’s current goal is to understand how tumors become resistant to therapies in order to identify new treatments for refractory cancers. Her research has been funded by notable organizations including the National Cancer Institute, the American Cancer Society, and the Pediatric Cancer Foundation.

Dr. Kandel has contributed widely to medical literature, publishing more than 60 peer-reviewed articles and three book chapters on angiogenesis and tumor growth. She currently serves as an editor for Oncology Letters and as an ad hoc reviewer for several other scientific journals. In addition, Dr. Kandel is a popular speaker and a dedicated educator, mentoring medical students, residents, and fellows on a range of research projects related to tumor modeling.

Michael Bishop, MD

Michael Bishop, MD (2013)
Department of Medicine

Michael R. Bishop, MD, specializes in the diagnosis and treatment of lymphomas and leukemias. In particular, he cares for patients with hematologic malignancies that have not responded to first-line treatments. An expert in hematopoietic stem cell transplantation (bone marrow transplantation), Dr. Bishop and his team are working to address the unique social, economic, physiological and biological issues that patients face while undergoing this treatment.

Dr. Bishop’s research focuses on the prevention and treatment of relapse after stem cell transplantation. Relapse is the primary cause of treatment failure and death after stem cell transplantation. He has served as the primary investigator on studies designed to prevent and treat disease recurrence after transplantation. Specifically, he works on ways to enhance immune effects of the transplanted cells against cancer.

An active contributor to medical literature, Dr. Bishop has authored more than 150 peer-reviewed articles, in addition to more than 30 book chapters and two books on cancer treatment and research. He also serves on the editorial board of numerous scientific journals, including Biology of Blood and Marrow Transplantation.

Dr. Bishop is a dedicated mentor, teaching residents and fellows in classroom, clinical and research settings. Many of his past trainees hold leadership roles in medical oncology and immunology at academic medical centers or at the National Cancer Institute in Bethesda, Maryland.

Since 2001, Dr. Bishop has consistently been named one of the "Best Doctors in America" by Best Doctors, Inc. He previously served as a senior investigator and as the clinical head of stem cell transplantation for the National Cancer Institute at the National Institutes of Health.

2013 Pilot Grant Project: A Pilot Program of Cost Communication in Hematologic Malignancies

Ross Milner

Ross Milner, MD (2012)
Department of Surgery

Dr. Milner attended medical school at the University of Pennsylvania and then completed his residency training in General Surgery as well as fellowship training in Vascular Surgery at the Hospital of the University of Pennsylvania. He received numerous teaching awards during his time as a resident and fellow at Penn. At the end of his fellowship, he was awarded the Marco Polo Fellowship from the Society for Vascular Surgery. As the Marco Polo Fellow, he worked at the University Medical Center, Utrecht, The Netherlands studying aortic aneurysmal disease and endovascular therapy. He performed the initial work investigating the value of remote pressure sensor use for surveillance of aneurysms after endovascular repair.

Following the fellowship, he joined the faculty at Emory University first as Assistant Professor and later as Associate Professor and Program Director of the Vascular Surgery fellowship. He moved to Chicago in 2009 after accepting the position of Chief of Vascular Surgery at Loyola University Medical Center. In January 2012, he was recruited to the University of Chicago Medicine as Associate Professor and Co-Director of the Center for Aortic Diseases. He is passionate about the care of vascular patients with a specific clinical and research focus on aortic aneurysm disease.

2013 Pilot Grant Project: “A Formal Curriculum in Surgical Professionalism and Ethics”: To enhance and encourage the professionalism of surgical residents and their understanding of the central concepts of surgical ethics

2013 Pilot Grant Project: Improving Professionalism for Physicians in Training: A Curriculum based Approach.